Stock Compensation Plan (Tables)

3 Months Ended

Mar. 31, 2025

Stock Compensation Plan

Schedule of Company's Stock Options

The following table sets forth the activity for the Company’s stock options during the periods presented:

	Number of Options			Weighted- Average Exercise Price per Share		Weighted Average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value
Outstanding as of December 31, 2024		2,731,000		$	1.90		7.4	$	7,171,930
Granted		—		$	—
Forfeited		(120,834	)	$	2.00
Outstanding as of March 31, 2025		2,610,166		$	1.90		7.1	$	7,283,847
Exercisable as of March 31, 2025		2,492,943		$	1.89		7.1	$	6,968,518
Vested or expected to vest as of March 31, 2025		2,610,166		$	1.90		7.1	$	7,283,847

Schedule of Summarizes Vesting of Restricted Common Stock

The following table summarizes vesting of restricted common stock:

	Number of Shares			Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2024		2,814,703		$	3.24
Vested		(457,115	)	$	3.14
Unvested as of March 31, 2025		2,357,588		$	3.26

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for all stock awards recognized in the accompanying consolidated statements of operations and comprehensive loss is as follows:

	Three Months Ended March 31,
	2025		2024
Selling, general and administrative	$	1,819,099	$	1,630,591
Research and development		70,602		83,063
Total	$	1,889,701	$	1,713,654